BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 16406275)

  • 1. In vivo determination of Neisseria meningitidis serogroup A capsular polysaccharide by whole cell high-resolution magic angle spinning NMR spectroscopy.
    Gudlavalleti SK; Szymanski CM; Jarrell HC; Stephens DS
    Carbohydr Res; 2006 Mar; 341(4):557-62. PubMed ID: 16406275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Neisseria meningitidis serogroup A capsular polysaccharide O-3 and O-4 acetyltransferase.
    Gudlavalleti SK; Datta AK; Tzeng YL; Noble C; Carlson RW; Stephens DS
    J Biol Chem; 2004 Oct; 279(41):42765-73. PubMed ID: 15294916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of structures corresponding to the capsular polysaccharide of Neisseria meningitidis group A.
    Slättegård R; Teodorovic P; Kinfe HH; Ravenscroft N; Gammon DW; Oscarson S
    Org Biomol Chem; 2005 Oct; 3(20):3782-7. PubMed ID: 16211114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative stability of meningococcal serogroup A and X polysaccharides.
    Berti F; Romano MR; Micoli F; Pinto V; Cappelletti E; Gavini M; Proietti D; Pluschke G; MacLennan CA; Costantino P
    Vaccine; 2012 Oct; 30(45):6409-15. PubMed ID: 22921741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformational studies of the capsular polysaccharide produced by Neisseria meningitidis group A.
    Foschiatti M; Hearshaw M; Cescutti P; Ravenscroft N; Rizzo R
    Carbohydr Res; 2009 May; 344(7):940-3. PubMed ID: 19306991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Four monoclonal antibodies against capsular polysaccharides of Neisseria meningitidis serogroups A, C, Y and W135: its application in identity tests.
    Reyes F; Amin N; Otero O; Aguilar A; Cuello M; Valdés Y; García LG; Cardoso D; Camacho F
    Biologicals; 2013 Jul; 41(4):275-8. PubMed ID: 23791517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and mechanistic basis of capsule O-acetylation in Neisseria meningitidis serogroup A.
    Fiebig T; Cramer JT; Bethe A; Baruch P; Curth U; Führing JI; Buettner FFR; Vogel U; Schubert M; Fedorov R; Mühlenhoff M
    Nat Commun; 2020 Sep; 11(1):4723. PubMed ID: 32948778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Full NMR assignment and revised structure for the capsular polysaccharide from Streptococcus pneumoniae type 15B.
    Jones C; Lemercinier X
    Carbohydr Res; 2005 Feb; 340(3):403-9. PubMed ID: 15680595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The HS:19 serostrain of Campylobacter jejuni has a hyaluronic acid-type capsular polysaccharide with a nonstoichiometric sorbose branch and O-methyl phosphoramidate group.
    McNally DJ; Jarrell HC; Khieu NH; Li J; Vinogradov E; Whitfield DM; Szymanski CM; Brisson JR
    FEBS J; 2006 Sep; 273(17):3975-89. PubMed ID: 16879613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Neisseria meningitidis serogroup W135 polysaccharide-tetanus toxoid conjugate vaccines made by periodate activation of O-acetylated, non-O-acetylated and chemically de-O-acetylated polysaccharide.
    Gudlavalleti SK; Lee CH; Norris SE; Paul-Satyaseela M; Vann WF; Frasch CE
    Vaccine; 2007 Nov; 25(46):7972-80. PubMed ID: 17936445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative proton nuclear magnetic resonance evaluation and total assignment of the capsular polysaccharide Neisseria meningitidis serogroup X.
    Garrido R; Puyada A; Fernández A; González M; Ramírez U; Cardoso F; Valdés Y; González D; Fernández V; Vérez V; Vélez H
    J Pharm Biomed Anal; 2012 Nov; 70():295-300. PubMed ID: 22877873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Full 1H NMR assignment and detailed O-acetylation patterns of capsular polysaccharides from Neisseria meningitidis used in vaccine production.
    Lemercinier X; Jones C
    Carbohydr Res; 1996 Dec; 296():83-96. PubMed ID: 9008844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of phosphono analogues of capsular polysaccharide fragments from Neisseria meningitidis A.
    Torres-Sanchez MI; Zaccaria C; Buzzi B; Miglio G; Lombardi G; Polito L; Russo G; Lay L
    Chemistry; 2007; 13(23):6623-35. PubMed ID: 17508372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformations of Neisseria meningitidis serogroup A and X polysaccharides: The effects of chain length and O-acetylation.
    Hlozek J; Kuttel MM; Ravenscroft N
    Carbohydr Res; 2018 Jul; 465():44-51. PubMed ID: 29940397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular cloning and functional characterization of components of the capsule biosynthesis complex of Neisseria meningitidis serogroup A: toward in vitro vaccine production.
    Fiebig T; Freiberger F; Pinto V; Romano MR; Black A; Litschko C; Bethe A; Yashunsky D; Adamo R; Nikolaev A; Berti F; Gerardy-Schahn R
    J Biol Chem; 2014 Jul; 289(28):19395-407. PubMed ID: 24849599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a high-resolution magic-angle spinning nuclear magnetic resonance identity assay of the capsular polysaccharide from Haemophilus influenzae type b present in cetavlon precipitate.
    Wieruszeski JM; Talaga P; Lippens G
    Anal Biochem; 2005 Mar; 338(1):20-5. PubMed ID: 15707931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunochemical studies and genetic background of two Neisseria meningitidis isolates expressing unusual capsule polysaccharide antigens with specificities of both serogroup Y and W135.
    Tsang RS; Tsai CM; Henderson AM; Tyler S; Law DK; Zollinger W; Jamieson F
    Can J Microbiol; 2008 Mar; 54(3):229-34. PubMed ID: 18388994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards a synthetic glycoconjugate vaccine against Neisseria meningitidis A.
    Berkin A; Coxon B; Pozsgay V
    Chemistry; 2002 Oct; 8(19):4424-33. PubMed ID: 12355530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous point mutations in the capsule synthesis locus leading to structural and functional changes of the capsule in serogroup A meningococcal populations.
    Ispasanie E; Micoli F; Lamelas A; Keller D; Berti F; De Riccio R; Di Benedettoi R; Rondini S; Pluschke G
    Virulence; 2018; 9(1):1138-1149. PubMed ID: 30067453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification, characterization and immunological properties of the capsular polysaccharide of Pasteurella haemolytica serotype T15: its identity with the K62 (K2ab) capsular polysaccharide of Escherichia coli and the capsular polysaccharide of Neisseria meningitidis serogroup H.
    Adlam C; Knights JM; Mugridge A; Lindon JC; Williams JM; Beesley JE
    J Gen Microbiol; 1985 Aug; 131(8):1963-72. PubMed ID: 3932592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.